Ventrus Biosciences (VTUS) Files $100M Mixed Shelf

Ventrus Biosciences Inc. (Nasdaq: VTUS) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Warrants, Debt Securities, Units, or any combination thereof.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jersey Mike's closes IPO at $23 per share on NYSE
• Qualcomm files to resell 17.8M shares tied to Modular acquisition
• Wallbox files to resell up to 13.9 million Class A shares